REGISTER
ERS 2026 | Patient Perspectives on Bronchiectasis Exacerbations | Prof. Eva Polverino
At the ERS Congress 2026, Prof. Eva Polverino discusses a multinational survey exploring how bronchiectasis affects patients’ lives. The interview highlights the social and emotional burden of exacerbations, reports of prolonged or incomplete recovery, and the importance of prevention. Earlier diagnosis and more personalized treatment are presented as priorities for the future.

Organised by the European Respiratory Society, ERS Congress 2026 took place in Barcelona, Spain, and online from 5–9 September, bringing together respiratory specialists and researchers to explore advances in respiratory medicine and science, including late-breaking trials and new ERS guidelines.

In this interview, Prof. Eva Polverino discusses a survey of more than 1,000 patients across the US and five European countries, exploring how bronchiectasis exacerbations affect social life, emotional wellbeing and recovery. The discussion acknowledges the limitations of self-reported data and highlights exacerbation prevention, earlier diagnosis and personalized treatment. Prof. Eva Polverino is based at Hospital Universitari Vall d’Hebron and Vall d’Hebron Institut de Recerca (VHIR) in Barcelona, and chairs the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) Management Committee.

Key highlights from this clip:

● The impact of bronchiectasis on social life, emotional wellbeing, daily activities and family life.

● How persistent cough and sputum can make social interactions difficult.

● Fear of future exacerbations and patient reports of prolonged or incomplete recovery.

● Why exacerbation prevention matters beyond the acute episode.

● Earlier diagnosis and identifying people at risk as future priorities.

● Investigating phenotypes and endotypes to support more personalized treatment. This video is intended for medical education and professional discussion.

0
0
Loading